Who are Markman Biologics Microsurfaced ADM's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/markman-biologics-microsurfaced-adm.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Markman Biologics Microsurfaced ADM — Competitive Intelligence Brief

Markman Biologics Microsurfaced ADM (Markman Biologics Microsurfaced ADM) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Acellular dermal matrix (ADM) / Tissue scaffold. Area: Reconstructive and Aesthetic Surgery.

marketed Acellular dermal matrix (ADM) / Tissue scaffold Reconstructive and Aesthetic Surgery Biologic Live · refreshed every 30 min

Target snapshot

Markman Biologics Microsurfaced ADM (Markman Biologics Microsurfaced ADM) — McGuire Institute. Markman Biologics Microsurfaced ADM is an acellular dermal matrix (ADM) product with a modified surface designed to improve integration and reduce complications in reconstructive surgery.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Markman Biologics Microsurfaced ADM TARGET	Markman Biologics Microsurfaced ADM	McGuire Institute	marketed	Acellular dermal matrix (ADM) / Tissue scaffold

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Acellular dermal matrix (ADM) / Tissue scaffold class)

McGuire Institute · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Markman Biologics Microsurfaced ADM — Competitive Intelligence Brief. https://druglandscape.com/ci/markman-biologics-microsurfaced-adm. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab